DIRS.INFO The most relevant business & tech news

☆ It’s time to get flu and Covid-19 shots
▼ + stars: | 2024-10-02 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +7 min

Vaccines for Covid-19, flu and RSV are available now. Covid-19 vaccinesThe CDC recommends that everyone ages 6 months and older receive a Covid-19 vaccine this season to stay up to date. Flu vaccinesThe CDC also recommends a seasonal flu vaccine for everyone ages 6 months and older. Unlike the flu and Covid-19 vaccines, the RSV vaccine is one-time dose. The CDC says it’s also acceptable to get Covid-19, flu and RSV shots at one time, for those who are eligible.

Persons: Janet Hamilton, “ We’re, ” Hamilton, “, There’s, it’s, Dr, Sanjay Gupta Organizations: CNN, Respiratory, of State, Territorial, US Centers for Disease Control, CDC, Moderna, Pfizer, —, CNN Health Locations: United States

Chin-Hong said the variant is a so-called recombinant of two other strains — KS.1.1 and KP.3.3 — meaning that genetic information was exchanged between them to form a third strain, XEC, Chin-Hong said. Is the XEC variant more contagious? Chan School of Public Health, said there’s no evidence yet that the XEC variant is much more transmissible than what’s currently circulating. The variant is closely related to KP.2, the strain targeted by the updated vaccines from Pfizer and Moderna. Bright, however, cautioned that clinical data is ultimately needed to determine how well the updated vaccines work against the XEC variant.

Persons: “, ”, Peter Chin, ” XEC, we’re, Rick Bright, Hong, Bill Hanage, ” Hanage, It’s, XEC, Hanage, “ It’s, Marc Johnson, Johnson, There’s, ” Chin, ” Johnson, ” Bright Organizations: Centers for Disease Control, Prevention, University of California, Biomedical, Research, Development Authority, Department of Health, Human Services, CDC, Harvard, of Public Health, University of Missouri School of Medicine, Pfizer, Moderna Locations: United States, San Francisco, Europe, Chin, U.S, Chan, Germany, Netherlands, France

☆ Free Covid-19 tests are available again. Here’s how to get them
▼ + stars: | 2024-09-26 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +3 min

CNN —People in the United States can now order more free Covid-19 tests from the federal government as the country heads into respiratory virus season with high levels of the coronavirus already circulating. “Reopening this popular program is the latest step by the Biden-Harris Administration to ensure that over-the-counter COVID-19 tests are available to all who want them this fall and winter,” HHS Assistant Secretary for Preparedness and Response Dawn O’Connell said in a statement. More information about ordering these tests is available at ACL.gov/AccessibleTests. The CDC also recommends that everyone age 6 months or older receive an updated Covid-19 vaccine this season to stay up to date. The updated Covid-19 vaccines are available now at pharmacies across the US and can be received at the same time as the annual flu vaccine.

Persons: Harris, Dawn O’Connell, “, Dr, Sanjay Gupta, Mandy Cohen, CNN’s Brenda Goodman Organizations: CNN, People, US Postal Service, US Department of Health, Human Services, Biden, Harris Administration, Preparedness, Administration, Strategic Preparedness, US Centers for Disease Control, US Food and Drug Administration, CNN Health, CDC, Moderna, Pfizer Locations: United States, COVIDTests.gov, COVID, Covid

☆ What to know about the available Covid-19, flu and RSV vaccines
▼ + stars: | 2024-09-16 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +8 min

But the Covid-19 vaccines provided 54% protection against symptomatic infection last season, CDC data shows, despite new variants that cropped up. The updated Covid-19 vaccines are available now, but ideal timing for getting the shot may differ based on individual circumstances. Unlike the flu and Covid-19 vaccines, the RSV vaccine is one-time dose. The CDC says it’s also acceptable to get Covid-19, flu and RSV shots at one time, for those who are eligible. Covid-19, flu and RSV vaccines are widely available at pharmacies across the US.

Persons: CNN —, There’s, Mandy Cohen, ”, ” Dr, Sandra Fryhofer, Fryhofer, Katelyn Jetelina, it’s, Dr, Sanjay Gupta Organizations: CNN, US Centers for Disease Control, CDC, Moderna, Pfizer, American Medical, —, CNN Health Locations: United States

Ron DeSantis’ administration is once again advising against the mRNA vaccines: this time in the most vulnerable residents. In updated guidance for health care providers released Thursday, the Florida Health Department and state Surgeon General Joseph Ladapo questioned the safety and effectiveness of the mRNA Covid vaccines from Pfizer and Moderna, including for older adults and people with underlying health problems. Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia, said the Florida surgeon general's guidance is unnecessarily alarming people about the Covid vaccines. "The mRNA vaccines are remarkably safe," he added. The CDC currently recommends everyone ages 6 months and older get an updated Covid vaccine this fall from any of the three options.

Persons: Ron DeSantis ’, Joseph Ladapo, Nature Cardiovascular Research , Paul Offit, Offit, They’re, Isaac Bogoch, ”, Boguch, Ladapo Organizations: Florida Health Department, Pfizer, Moderna, Nature Cardiovascular Research, Children’s Hospital of Philadelphia, Food and Drug Administration, United States, University of Toronto, CDC, Emergency Locations: Florida, U.S

☆ New Covid shots are coming available. Here’s what experts say about when to get yours
▼ + stars: | 2024-08-23 | by ( Brenda Goodman | ) edition.cnn.com time to read: +5 min

CNN —Newly updated vaccines against Covid-19 will be in pharmacies soon, just as the US is experiencing a surge of infections. Experts say it depends on your health, whether you’ve recently had Covid-19, which vaccine you plan to get and when it’s convenient for you. For that reason, he’s going to hold off on getting the updated shot. Ranney noted that the updated mRNA shots from Pfizer and Moderna will probably be available first, with Novavax’s vaccine coming in a few weeks. “The reality is that we’ve had waves of Covid every summer for the last few years, and so I think we have to kind of do a reset or rethink about how we’re doing Covid vaccine delivery,” Hotez said.

Persons: you’ve, “ It’s, ”, Carlos del Rio, “, You’ve, Del, Paul Offit, Megan Ranney, Ranney, Peter Chin, “ I’m, I’m, you’re, ” Chin, Hong, Dr, Sanjay Gupta, Peter Hotez, ” Hotez Organizations: CNN, Covid, Emory University, Vaccine Education, Children’s Hospital of Philadelphia, Food, Yale School of Public Health, Pfizer, Moderna, University of California, ”, CNN Health, Texas Children’s Hospital Locations: Del Rio, San Francisco, Texas

☆ Here are 4 things we're watching closely in the stock market this week
▼ + stars: | 2024-08-04 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. Until then, bad economic news was good news for the stock market, because it meant the Federal Reserve would start cutting interest rates sooner. On Thursday, a drop in U.S. manufacturing activity for July and a jump in initial jobless claims dragged down the market. Next week is light on economic data, so expect earnings reports and CEO commentaries to drive the market action. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stocks, Dow Jones, Jim Cramer, would've, Eli Lilly, Mounjaro, Berkshire Hathaway, Krystal, Tyson, BAX, Owens, Walt, Oscar Health, CRON, Krispy, Papa, Jim Cramer's, Jim Organizations: Nasdaq, Dow, Reserve, Broadcom, Devices, Palo Alto, PMI, Wynn Resorts, Investors, Wynn, Wynn Palace, U.S . Disney, Management, and Drug Administration, Carlyle Group, Krystal Biotech, Tyson Foods, TSN, Alpha Metallurgical Resources, BioCryst Pharmaceuticals, Axsome Therapeutics, Technologies, Clover Health, Realty Income Corp, Avis Budget Group, CSX Corp, CSX, Simon Property Group, Sterling Construction Company, Teradata Corp, Yum China Holdings, ZoomInfo Technologies, Holdings, Caterpillar, Baxter International, Vulcan Materials Company, Allegheny Technologies Incorporated, Constellation Energy Group, Marathon Petroleum Corp, Owens Corning Inc, Duke Energy Corp, GXO Logistics, Brands, Builders, Wynn Resorts Ltd, WYNN, Rivian Automotive, Devon Energy Corp, GigaCloud Technology Inc, Lumen Technologies, VF Corp, Walt Disney Co, Novo Nordisk, CVS Health, Aurora Cannabis Inc, Emerson Electric Co, Sony Group Corporation, SONY, Inc, ODP Corporation, Icahn Enterprises, MannKind Corp, ACM Research, Brink's Company, AppLovin Corporation, Digital Turbine, Sarepta Therapeutics, Occidental Petroleum Corp, Bros, SolarEdge Technologies, Aspen, Coeur D'Alene Mines Corp, Co, Vistra Energy, Cheniere Energy, Cronos, Himax Technologies, Properties Trust, Papa John's, Paramount Global, Trade, Lab, B2Gold Corp, Honest Company, Gilead Sciences, Growth, Nikola Corporation, Embraer, New Fortress Energy, Construction, Jim Cramer's Charitable, CNBC, Disney, Pixar Locations: Palo, Macau, Las Vegas, Boston, Vegas, Wynn Macau, China, Novo, Coeur, Gilead

☆ Here are Tuesday's biggest analyst calls: Nvidia, Apple, Roblox, Netflix, Amazon, Tesla, McDonald's, Affirm & more
▼ + stars: | 2024-07-30 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Loop initiates BrightView as buy Loop said it's bullish on shares of the commercial landscaping company. Evercore ISI reiterates Apple as outperform Evercore said it's bullish ahead of Apple earnings later this week. " Bank of America reiterates Roblox as buy Bank of America said it's standing by Roblox ahead of earnings on August 1. Deutsche Bank reiterates McDonald's as buy Deutsche said it's standing by the fast food giant following earnings. Bank of America reiterates Goldman Sachs as buy Bank of America said top pick Goldman Sachs has "cyclical/secular tailwinds."

Persons: Evercore, it's, Jensen Huang, Nvidia's Blackwell, Blackwell, KBW, Oppenheimer, Wells, Roblox, Tesla, McDonald's, Baird, Edward Jones, Goldman Sachs, ROE resiliency, Morgan Stanley, Wells Fargo Organizations: Apple, Citi, Nvidia, " Bank of America, of America, Barclays, UBS, Amazon, Netflix, Bank of America, JPMorgan, RBC, Tesla, Deutsche Bank, Deutsche, Whirlpool, underperform Bank of America, Abbott Laboratories, Abbott Labs, Edward, Stock, 2Q, PNC, WF

Analyst Alex Henderson reiterated his buy rating for the cybersecurity firm but lowered his price target to $375 from $425. JPMorgan analyst Kenneth Worthington attributed a higher assumption for total crypto market cap as one reason for his price target raise. "We see the cryptoecosystem in the midst of a material participation rally, benefitting Coinbase revenue generation near term," the analyst wrote. Analyst Eric Joseph's December 2025 price target of $8 implies a 51% decline ahead for the stock. He also maintained his $725 price target, which implies upside of 15.6% from Monday's close.

Persons: Oppenheimer, Needham, Alex Henderson, CrowdStrike, Henderson, Lisa Kailai Han, Keefe, Bruyette, Meyer Shields, Shields, — Lisa Kailai Han, Kenneth Worthington, JPMorgan downgrades, Eric Joseph's, Joseph, Chipmaker, Simon Coles, Coles, Jason Helfstein, NFLX, Fred Imbert Organizations: CNBC, Barclays, Netflix, Security, Aon, JPMorgan, Sanofi Locations: Woods, Coinbase, China, Monday's

☆ Cramer's Lightning Round: 'Let's stay away' from Unity Software
▼ + stars: | 2024-06-14 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Vistra's year-to-date stock performance. "Stock Chart Icon Stock chart icon Novavax's year-to-date stock performance. Stock Chart Icon Stock chart icon Twilio's year-to-date stock performance. Stock Chart Icon Stock chart icon H.B. Stock Chart Icon Stock chart icon Unity Software's year-to-date stock performance.

Persons: it's, Fuller, It's, Let's Organizations: Unity Software, Ardagh Locations: Fuller's

☆ Lightning Round: Stay away from Unity Software, says Jim Cramer
▼ + stars: | 2024-06-14 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Stay away from Unity Software, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Vistra, Novavax, Twilio, H.B. Fuller, Ardagh Metal Packaging, and SoFi.

Persons: Jim Cramer, Fuller Organizations: Unity Software, Packaging

☆ CNBC Daily Open: Apple upgrades Siri with AI
▼ + stars: | 2024-06-11 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Apple IntelligenceShares of Apple fell 1.9% after the iPhone maker delivered its long-awaited AI strategy. Siri will get an upgrade with Apple Intelligence and access to OpenAI's ChatGPT. Investors are concerned Apple had fallen behind its rivals, Microsoft and Google, in the race to deliver AI services and tools.

Persons: Goldman Sachs, Siri, Apple, Elon Musk's, Chris Ailman, CNBC's, Ailman, CalSTRS, Elliott, Moderna, Tesla, Elon, Bernstein Organizations: CNBC, Nasdaq, Technology, Nvidia, Meta, Microsoft, Dow Jones, Apple Intelligence, Apple, Investors, Google, California State Teachers, Elliott, Southwest, Elliott Management, Southwest Airlines, Boeing, Pfizer, Novavax Locations: U.S

☆ Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
▼ + stars: | 2024-06-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. Moderna's messenger RNA combination shot, called mRNA-1083, is made up of both the company's vaccine candidate for seasonal influenza and a newer, "next-generation" version of its Covid shot. The study compared the combination shot with an enhanced flu vaccine called Fluzone HD and Moderna's currently licensed Covid shot, Spikevax, in one group of patients ages 65 and above. Moderna is also developing a combination shot targeting the flu and RSV, and another vaccine targeting all three respiratory viruses: Covid, flu and RSV. Meanwhile, Pfizer and BioNTech also are studying a vaccine that targets both Covid and the flu in a late-stage trial.

Persons: Stephane Bancel, Novavax, Bancel, Moderna, BioNTech Organizations: Pfizer, Novavax, Moderna, Covid Locations: U.S

☆ Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
▼ + stars: | 2024-05-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company's new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the struggling vaccine maker. Novavax's stock almost doubled on Friday after it announced the licensing agreement with Sanofi. Under the agreement, Sanofi will take a less than 5% stake in Novavax. Sanofi, one of the world's largest vaccine makers, will co-market Novavax's Covid vaccine in most countries starting in 2025. The deal also allows Sanofi to use Novavax's Covid shot and flagship vaccine technology, Matrix-M adjuvant, to develop new vaccine products.

Persons: Novavax, Sanofi, John Jacobs Organizations: French, Sanofi, Novavax, CNBC Locations: Novavax

☆ Stocks making the biggest moves premarket: Yelp, Sweetgreen, Novavax, Akamai Technologies and more
▼ + stars: | 2024-05-10 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

Akamai Technologies — Shares of the cloud company fell more than 10% after issuing weak guidance for the second quarter. Akamai sees adjusted earnings ranging from $1.51 to $1.56 per share on revenue of $967 million to $986 million. Sweetgreen — The salad chain popped 5% after Sweetgreen reported first-quarter revenue of $158 million, topping the LSEG consensus estimate of $152 million. Analysts polled by FactSet called for a loss of 4 cents a share on revenue of $141.2 million. The DNA testing company posted a loss of 56 cents per share, while analysts had estimated a loss of 71 cents, per StreetAccount.

Persons: Akamai, Sweetgreen, Array's, FactSet, Bumble, StreetAccount, LSEG, Sanofi, Yelp's, Macheel, Jesse Pound, Michelle Fox Organizations: LSEG, —, Gen, Revenue, Management, Unity Software, HSBC, 3M Locations: Norton

☆ Stocks making the biggest moves midday: Novavax, Taiwan Semiconductor, Sweetgreen and more
▼ + stars: | 2024-05-10 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

Sweetgreen — Sweetgreen popped 36% after surpassing first-quarter revenue expectations. The company also raised its full-year guidance for revenue and adjusted earnings before interest, taxes, depreciation and amortization. Array's first-quarter adjusted earnings came in at 6 cents per share on revenue of $153.4 million. Victoria's Secret — Shares rose almost 6% after the intimate apparel maker reported better-than-expected preliminary first-quarter results and reaffirmed its guidance. Mettler-Toledo posted first-quarter adjusted earnings of $8.89 per share on revenue of $925.9 million.

Persons: Sanofi, Sweetgreen, LSEG, Array's, FactSet, Natera, Insulet, JFrog, Yun Li, Michelle Fox, Brian Evans, Hakyung Kim, Darla Mercado Organizations: French, Taiwan Semiconductor Manufacturing, Unity Software, LSEG, Technologies, Akamai Technologies, Revenue, —, Norton, Citi, Toledo —, Mettler Locations: Toledo

☆ Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
▼ + stars: | 2024-05-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company's Covid vaccine starting next year and develop combination shots targeting the coronavirus and the flu, among other efforts. Part of the deal allows Sanofi to use Novavax's Covid shot and flagship vaccine technology, Matrix-M adjuvant, to develop new vaccine products. Novavax is also entitled to royalty payments on Sanofi's sales of its Covid vaccine and combination shots targeting coronavirus and the flu. Under the deal, Sanofi will also take a less than 5% stake in Novavax.

Persons: Novavax, Sanofi, John Jacobs, Jacobs Organizations: Dutch Health Service Organization, French, CNBC, Health, Pfizer, Moderna, Sanofi Locations: The Hague, Netherlands, Novavax

As the market continued to soar this month, hedge funds are betting against a handful of health-care and auto stocks. CNBC Pro used FactSet data to look for stocks trading on the New York Stock Exchange and Nasdaq Exchange with the most short interest as of Feb. 15. Here are the names of these heavily shorted stocks: Some health-care stocks saw a sizable increase in short interest. Biomea Fusion saw short interest increase by about 19% to 11.8 million shares, or about 43% of float. Children's Place saw short interest increase by more than 200% during the first half of February.

Organizations: Nasdaq, Dow Jones, CNBC, New York Stock Exchange, Nasdaq Exchange, Biomea, Traders, Children's, Mithaq Capital, Lucid Locations: Children's, Saudi

☆ Novavax stock falls 20% as vaccine maker misses quarterly estimates, sees sluggish 2024 sales
▼ + stars: | 2024-02-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Novavax generated fourth-quarter sales of $291.3 million, down from the $357.4 million in the year-earlier period. Novavax expects full-year 2024 revenue to come in between $800 million and $1 billion. Novavax anticipates first-quarter revenue to come in at $100 million, which reflects the tail end of the current Covid vaccination season. The cuts will help Novavax focus on further developing its combination vaccine targeting Covid and the flu, which it plans to launch in 2026. On Thursday, Novavax said it will settle a bitter arbitration dispute with Gavi, a nongovernmental global vaccine organization, over a canceled Covid vaccine purchase agreement.

Persons: Novavax, John Jacobs, Jacobs, Gavi Organizations: LSEG, CNBC, CNBC PRO

☆ Stocks making the biggest moves midday: Bumble, Beyond Meat, eBay, Urban Outfitters and more
▼ + stars: | 2024-02-28 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +5 min

Beyond Meat reported fourth-quarter revenue of $73.7 million, versus the $66.7 million consensus estimate, per LSEG, formerly known as Refinitiv. First Solar — Shares added more than 3% after the solar panel manufacturer reported a fourth-quarter earnings beat . Urban Outfitters — The clothing retailer plunged 15% after missing estimates for its fourth-quarter earnings and revenue. Axon Enterprise — The weapons manufacturer popped 14% after reporting a fourth-quarter earnings beat. Novavax — The vaccine maker slid 27% after Novavax missed Wall Street's estimates for its fourth-quarter revenue and earnings .

Persons: Bumble —, Bumble, FactSet, Lemonade, Viatris, LSEG, —, Novavax, Axel Springer, Schibsted, — CNBC's Brian Evans, Michelle Fox, Alexander Harring, Pia Singh, Samantha Subin Organizations: Advance, FactSet, eBay, Baidu, U.S . Securities, Exchange Commission, Attorney's, District of Massachusetts, Materials, Urban Outfitters, Boeing —, Federal Aviation Administration, Boeing, Alaska Airlines, Street, Justice Department Locations: U.S, China

☆ Fed's favorite inflation gauge looms next week — plus, what we want from 2 portfolio earnings reports
▼ + stars: | 2024-02-24 | by ( Zev Fima | ) www.cnbc.com time to read: +10 min

Wall Street returned to its winning ways this week — and Nvidia 's blowout earnings report Wednesday night was a big reason why. Twenty-six of our 32 portfolio stocks have delivered their results this earnings season (we didn't own Abbott Labs at the time of its report). It was a muted week for macroeconomic data, but we did get a slightly better-than-expected January existing home sales report on Thursday. In the week ahead, two more Club names are set to report earnings before a market-moving economic update arrives Thursday morning. The two other reports of note are the January new home sales report on Monday and ISM Manufacturing report on Friday.

Persons: Dow, we'll, bode, We're, Li Auto, Krystal, Arcutis, MARA, Iovance, Goldman Sachs BDC, CRON, BUD, Papa, LEV, Ginkgo, Jim Cramer's, Jim Cramer, Jim, Spencer Platt Organizations: Nvidia, Nasdaq, Dow Jones, Dow, Palo Alto Networks, Bausch Health, Coterra Energy, Abbott, Companies, TJX, Marshalls, TJX Companies, Berkshire Hathaway, Krystal Biotech, Alpha Metallurgical Resources , Inc, Fidelity National Information Services Inc, Animal Health, ELAN, Public Service Enterprise Group, Surgery Partners, BioCryst Pharmaceuticals Inc, Outdoor Holdings, Enlight Renewable Energy Ltd, Kosmos Energy, Playtika, Video Communications, TiRobot Corp, IRB, SBAC Communications Corporation, HEICO Corporation, FS KKR, Archer Aviation Inc, TransMedics, Sterling Construction Company, AES, Cruise Line Holdings, Lowe's Companies, American Electric Power Company, Bank of Nova, APLS Pharmaceuticals, Bank of Montreal, BMO, Devon Energy, Solar Inc, Technologies, Lab, Virgin Galactic Holdings, Splunk Inc, eBay, EBAY, Luminar Technologies, Agilent Technologies, G Foods, Masimo Corp, Baidu, Parts Inc, Icahn Enterprises, Viatris Inc, ACM Research, Golden Ocean Group, EMCOR, Industries, NRG Energy, Dycom, Editas, UWM Holdings Corporation, Vistra Energy, Marathon Digital Holdings, AMC Entertainment Holdings, Paramount Global, IonQ Inc, International, HP, Monster Beverage Corporation, Cronos, Birkenstock Holding, Anheuser, Busch InBev, Body, Brink's Company, Flags Inc, Papa John's, ACI, Hormel, Lion Electric Company, BlackRock TCP, Dole plc, DOLE, Fisker Inc, Dell Technologies, Ginkgo Bioworks Holdings, Autodesk, Green Brick Partners, Hewlett Packard Enterprise, Veeva Systems, INTTEST Corporation, Jim Cramer's Charitable, CNBC, New York Stock Exchange, Getty Locations: New York City, U.S, Salesforce, Maxx, Bank of Nova Scotia, BlackRock, Cayman

☆ CNBC Daily Open: The U.S. economy is humming along
▼ + stars: | 2024-02-23 | by ( Sumathi Bala | ) www.cnbc.com time to read: +1 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Historic moon landingIntuitive Machines IM-1 mission has landed on the moon, in a historic first for a U.S. company. The company's Nova-C cargo lander, named "Odysseus," is the first American spacecraft to land on the lunar surface since 1972. [PRO] 'Seven Samurai'With Japanese markets enjoying a bull run, Goldman Sachs has named "Seven Samurai" stocks in the country, which it highlighted could be to equivalent to the U.S.'s "Magnificent Seven."

Persons: Dow, Reddit, Odysseus, Goldman Sachs Organizations: CNBC, Nasdaq, Social, Securities and Exchange Commission, New York Stock Exchange Locations: U.S

☆ Novavax to settle dispute over canceled Covid vaccine purchase agreement
▼ + stars: | 2024-02-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Novavax on Thursday said it will settle a bitter arbitration dispute with Gavi, a nongovernmental global vaccine organization, over a canceled Covid vaccine purchase agreement. In 2022, Novavax terminated a purchase agreement with Geneva-based Gavi. Under the settlement, Novavax has paid an initial $75 million to Gavi and will make deferred payments of $80 million each year through Dec. 31. Analysts had previously told CNBC that Novavax could "be in trouble" if the arbitration forced it to pay the full $700 million to Gavi in 2023.

Persons: Novavax, Gavi, bode, David Marlow Organizations: Dutch Health Service Organization, CNBC Locations: The Hague, Netherlands, Geneva, Novavax

☆ Stocks making the biggest moves before the bell: Nvidia, Moderna, Rivian, Etsy and more
▼ + stars: | 2024-02-22 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

The company also said revenue in the current quarter would be stronger than Wall Street forecasted. Moderna — Shares were up more than 5% after the vaccine maker posted a greater-than-expected revenue for the fourth quarter. The company's top line registered at $2.81 billion, while analysts polled by LSEG had forecast a print of $2.50 billion. Lucid — Shares pulled back more than 7% after the luxury electric vehicle company missed revenue estimates in the fourth-quarter. Specifically, Lucid posted $157 million, while analysts expected $180 million, per LSEG.

Persons: LSEG, Lucid, Cantor Fitzgerald, —, Rivian, Synopsys, Morgan Stanley, FactSet, Remitly, TD Cowen, Oliver Chen, KeyBanc, — CNBC's Brian Evans, Lisa Kailai Han, Fred Imbert, Sarah Min Organizations: Nvidia, Wall, —, Moderna, LSEG, BMO Capital Markets, Coty —, ASML, HSBC, Gates Locations: Thursday's premarket, Wednesday's

☆ Stocks making the biggest moves midday: Nvidia, Rivian, Moderna, Novavax and more
▼ + stars: | 2024-02-22 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +4 min

Nvidia earned $5.16 per share on an adjusted basis and $22.1 billion in revenue, higher than the $4.64 per share and $20.62 billion analysts polled by LSEG had expected. Moderna — Shares popped 12% after the vaccine maker beat fourth-quarter revenue expectations , lifted by deferred revenue and cost cuts. Moderna's top line came out to be $2.81 billion, while analysts polled by LSEG had expected $2.50 billion. Quanta Services — The infrastructure stock popped nearly 10% following a fourth-quarter earnings beat. Keurig Dr Pepper reported $3.87 billion in in fourth quarter revenue, below the $3.92 billion expected by analysts, according to FactSet.

Persons: LSEG, Cantor Fitzgerald, Etsy, Rivian, Synopsys, Morgan Stanley, Coty —, TD Cowen, FactSet, Keurig Dr Pepper, Dr Pepper, — CNBC's Michelle Fox, Alexander Harring, Yun Li, Jesse Pound, Pia Singh, Samantha Subin Organizations: Nvidia, Moderna, LSEG, Coty, Scotiabank, Mosaic

Search resuls for: "Novavax"

25 mentions found